Bar graphs showing lenvatinib signature (left panel) and sorafenib signature (right panel) predictions for relapsed patients with both RNA-seq profiled multi-region organoids and clinical response from the treatment of individual drug. Bar colors indicate the predicted response by the expression signature, and patient clinical response are indicated at horizontal axis. Signature prediction score were indicated by the left y axis, while drug sensitivity results by the right y axis.
